By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Generon (Shanghai) Corporation Ltd.  

Suite 302/303, Building 9
1011 Ha Lei Road, Z.J. Hi-Tech Park
  Shanghai  201203   China
Phone: 8621-51320626 Fax: 8621-51320623


SEARCH JOBS


Industry
Biotechnology






Company News
Generon (Shanghai) Corporation Ltd. Announces The Initiation Of A Phase I Clinical Study For A-337, A CD3-Activating Bi-Specific Antibody Targeting Epcam To Treat Solid Tumors 6/15/2017 6:56:56 AM
Generon (Shanghai) Corporation Ltd. Collaborating With Mayo Clinic To Initiate A Phase IIa Study With F-652, A First-In-Class Biologic, To Treat Patients With Alcoholic Hepatitis 11/23/2015 8:29:31 AM
Generon (Shanghai) Corporation Ltd. Received FDA Clearance To Initiate Phase IIa Study With F-652, A First-In-Class Biologic, To Treat Patients With Acute GvHD 5/4/2015 8:14:53 AM
Generon (Shanghai) Corporation Ltd. Presents The Global Phase 2 Study Results For F-627 (Benegrastim) At American Society of Hematology 56th Annual Meeting At San Francisco 12/8/2014 11:20:08 AM
Generon (Shanghai) Corporation Ltd. Initiates a Phase I Clinical Study for F-652 in Australia 9/6/2012 7:40:14 AM
Generon (Shanghai) Corporation Ltd. Initiates a Phase II Clinical Trial for F-627 after US FDA Clearance 5/4/2012 10:22:58 AM
//-->